MGTX
Companies
NASDAQ
MeiraGTx Holdings plc
Health Care
$6.48
+$0.23 (+3.78%)
Price Chart
Overview
About MGTX
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Market Cap
$306.7M
Volume
4.6M
Avg. Volume
4.0M
P/E Ratio
6.6265063
Dividend Yield
0.00%
Employees
383.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.38
High Correlation
Volatility
High (0.61)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, MGTX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$306.7M
Volume4.6M
P/E Ratio6.63
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 13, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025